These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9409306)

  • 41. Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE.
    Wu R; Svenungsson E; Gunnarsson I; Andersson B; Lundberg I; Schäfer Elinder L; Frostegård J
    Lupus; 1999; 8(2):142-50. PubMed ID: 10192509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of serum C3 levels with the risk of myocardial infarction.
    Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
    Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
    Lopes-Virella MF; Hunt KJ; Baker NL; Virella G; Moritz T;
    Atherosclerosis; 2012 Oct; 224(2):526-31. PubMed ID: 22963984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.
    Virella G; Carter RE; Saad A; Crosswell EG; Game BA; ; Lopes-Virella MF
    Clin Immunol; 2008 Jun; 127(3):394-400. PubMed ID: 18533284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.
    Eichinger S; Kyrle PA; Kammer M; Eischer L; Ozsvar Kozma M; Binder CJ
    J Thromb Haemost; 2018 Jan; 16(1):31-35. PubMed ID: 29045005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between oxidized LDL, IgM, and IgG autoantibodies to ox-LDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction.
    Crisby M; Henareh L; Agewall S
    Angiology; 2014 Nov; 65(10):932-6. PubMed ID: 24288363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M.
    Kovanen PT; Mänttäri M; Palosuo T; Manninen V; Aho K
    Arch Intern Med; 1998 Jul; 158(13):1434-9. PubMed ID: 9665352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-reactive saliva IgA antibodies to oxidized LDL and periodontal pathogens in humans.
    Akhi R; Wang C; Kyrklund M; Kummu O; Turunen SP; Hyvärinen K; Kullaa A; Salo T; Pussinen PJ; Hörkkö S
    J Clin Periodontol; 2017 Jul; 44(7):682-691. PubMed ID: 28548243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The metabolic syndrome, smoking, and antibodies to oxidized LDL in 58-year-old clinically healthy men.
    Fagerberg B; Bokemark L; Hulthe J
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):227-35. PubMed ID: 11831108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.
    Bellomo G; Maggi E; Poli M; Agosta FG; Bollati P; Finardi G
    Diabetes; 1995 Jan; 44(1):60-6. PubMed ID: 7813815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serologic response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction.
    Mattila K; Vaarala O; Palosuo T; Malkamäki M; Valtonen V; Nieminen M; Aho K
    Clin Immunol Immunopathol; 1989 Jun; 51(3):414-8. PubMed ID: 2721035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients.
    Maiolino G; Pedon L; Cesari M; Frigo AC; Barisa M; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
    Int J Cardiol; 2013 Sep; 168(1):484-9. PubMed ID: 23102599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension.
    Türkoğlu O; Bariş N; Kütükçüler N; Senarslan O; Güneri S; Atilla G
    J Periodontol; 2008 Feb; 79(2):332-40. PubMed ID: 18251648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticardiolipin antibodies are no marker for survived myocardial infarction.
    Eber B; Kronberger-Schaffer E; Brussee H; Klima G; Obernosterer A; Toporsch M; Dusleag J; Klein W
    Klin Wochenschr; 1990 Jun; 68(12):594-6. PubMed ID: 2376955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneity of autoantibodies against cardiolipin and oxidatively modified LDLs revealed by human monoclonal antibodies.
    Lefvert AK
    J Intern Med; 2000 Mar; 247(3):385-90. PubMed ID: 10762456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.
    Cremer P; Nagel D; Mann H; Labrot B; Müller-Berninger R; Elster H; Seidel D
    Atherosclerosis; 1997 Mar; 129(2):221-30. PubMed ID: 9105565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Retrospective Study on the Association between Thyroid Autoantibodies with β2-glycoprotein and Cardiolipin Antibodies in Recurrent Miscarriage.
    Promberger R; Walch K; Seemann R; Pils S; Ott J
    Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):72-76. PubMed ID: 28417627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoantibodies against oxidized low-density lipoprotein in cerebral small vessel disease.
    Rouhl RP; van Oostenbrugge RJ; Theunissen RO; Knottnerus IL; Staals J; Henskens LH; Kroon AA; de Leeuw PW; Lodder J; Tervaert JW; Damoiseaux JG
    Stroke; 2010 Nov; 41(11):2687-9. PubMed ID: 20947847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.